American Century Companies’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
DTC
TCM
RCM
American Century Companies's ALT Position: Q2 2026 in Review
American Century Companies sold out of Altimmune (ALT) in Q2 2026, closing a stake of 62,909 shares — an estimated $194K sold.
American Century Companies first reported a position in ALT in Q4 2016 and held it in 11 quarters. The position peaked at $801K in Q1 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- American Century Companies reported no remaining Altimmune position as of Q2 2026 after selling out during the quarter.
- American Century Companies sold 62,909 Altimmune shares in Q2 2026, an estimated $194K.
- American Century Companies first reported a position in Altimmune in Q4 2016 and held it in 11 quarters.
- American Century Companies's Altimmune position peaked at $801K in Q1 2024.
- 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.